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7 Summary 
Effects of latent membrane protein 2A expression und constitutive 
nuclear factor-κB activity on B cell development in mice 
Hodgkin lymphoma are among the most frequent malignant lymphoid disorders. The 
Hodgkin/Reed Sternberg (H/RS) cells, the malignant cells of the lymphoma, are B 
cell derived. The molecular pathogenesis of these cells is unknown to date. Common 
features of more than 50 % of H/RS cells are the constitutive activity of the 
transcription factor Nuclear Factor (NF) -κB und the expression of the Epstein-Barr 
virus latent membrane protein 2A (LMP2A).  
Aim of this study was to establish a mouse model with constitutively active NF-κB 
und LMP2A expression. The effects of these factors on B-cells in mice were 
investigated. 
To establish the model modified fetal haematopoietic stem cells were transplanted 
into B cell deficient recipients. The donor haematopoietic stem cells were extracted 
from foetuses with a knockout of the NF-κB-inhibitor IκBα. Before transplantation 
they were transfected with a retrovirus encoding for LMP2A. Haematopoietic stem 
cells that were infected with the LMP2A retrovirus from wildtype IκBα foetuses 
served as controls. Mice with defined genetic changes in their B cell population were 
analysed. 
Five weeks after transplantation the recipients showed constitutive NF-κB activity 
und LMP2A expression in haematopoietic cells. This model enabled us to analyse 
effects of permanent NF-κB activity und expression of LMP2A in combination in vivo. 
Flowcytometric analysis showed lower fractions of B cells when LMP2A was 
expressed. Additionally the fraction of high IgM expressing B cells decreased. 
Transcriptional downregulations of B cell specific differentiation factors EBF und 
Pax5 could be the reasons for this. In EBF und Pax5 knockout mice B cell 
development is blocked in the pro-B cell stage. 
Additionally, proliferation assays demonstrated decreased proliferative responses of 
LMP2A expressing B-cells to B cell specific stimuli. The inhibition of proliferation und 
the down regulation of the transcription of B-cell specific transcription factors (EBF 
und Pax5, shown in RT-PCR analysis) revealed deregulated differentiation und 
proliferation of the B-cells. 
Permanent NF-κB activity increased B-cell proliferation after stimulation. That means 
it lead to advantages in survival compared to cells with physiological NF-κB activity. 
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NF-κB as well as LMP2A increased transcription of the receptor und transcription 
factor Notch1. It was already shown that Notch1 is active in H/RS cells und provides 
proliferative und antiapoptotic effects. NF-κB und LMP2A might use the Notch1 
signalling pathway to protect B-cells from cell death. 
This mouse model enabled us to show that permanent NF-κB activity und LMP2A 
expression are not sufficient to turn B-cells malignant like H/RS cells. Nevertheless, 
analysis demonstrated strong effects on B-cells und their transformation. NF-κB 
increases the tumor potentials of B-cells by increasing proliferation. Both factors 
decrease transcription of the transcription factors EBF und Pax5. 
